Ngā hua rapu kaituhi

1

Suicide rate 22 years after parasuicide: cohort study mā Gisli Jenkins

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Ligation of protease-activated receptor 1 enhances v 6 integrin-dependent TGF- activation and promotes acute lung injury mā Gisli Jenkins

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

The pathogenesis of idiopathic pulmonary fibrosis mā William R. Coward, Gauri Saini, Gisli Jenkins

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy mā Peter M. George, Athol U. Wells, Gisli Jenkins

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis mā James M. May, Jane A. Mitchell, Gisli Jenkins

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts mā Alison E. John, Chitra Joseph, Gisli Jenkins, Amanda L. Tatler

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis mā William R. Coward, Keira Watts, Carol Feghali‐Bostwick, Gisli Jenkins, Linhua Pang

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase‐2 in idiopathic pulmonary fibrosis mā William R. Coward, Carol Feghali‐Bostwick, Gisli Jenkins, Alan J. Knox, Linhua Pang

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Interplay between EZH2 and G9a Regulates<i>CXCL10</i>Gene Repression in Idiopathic Pulmonary Fibrosis mā William R. Coward, Stephan Brand, Alice Pasini, Gisli Jenkins, Alan J. Knox, Linhua Pang

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in<i>ex vivo</i>precision-cut lung slices mā Amanda L. Tatler, Josephine L. Barnes, Anthony Habgood, Amanda Goodwin, Robin J. McAnulty, Gisli Jenkins

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
11

British Thoracic Society survey of rehabilitation to support recovery of the post-COVID-19 population mā Sally Singh, Amy Barradell, Neil Greening, Charlotte E. Bolton, Gisli Jenkins, Louise Preston, John R. Hurst

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19 mā Fasihul Khan, Iain Stewart, Laura Fabbri, Samuel Moss, Karen A. Robinson, Alan R Smyth, Gisli Jenkins

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Emerging therapeutic opportunities for integrin inhibitors mā Robert J. Slack, Simon J. F. Macdonald, James A. Roper, Gisli Jenkins, Richard J. D. Hatley

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis mā Francesco Lombardi, Iain Stewart, Laura Fabbri, Wendy Adams, Letícia Kawano-Dourado, Christopher J. Ryerson, Gisli Jenkins

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

The rising incidence of idiopathic pulmonary fibrosis in the UK mā Vidya Navaratnam, Kate M. Fleming, Joe West, C. J. P. Smith, Gisli Jenkins, A. Fogarty, Richard Hubbard

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia mā Rebecca J Calthorpe, Caroline Poulter, Alan R Smyth, Don Sharkey, Jayesh Bhatt, Gisli Jenkins, Amanda L. Tatler

I whakaputaina 2023

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease mā Gauri Saini, Joanne Porte, Paul H. Weinreb, Shelia M. Violette, William Wallace, Tricia M. McKeever, Gisli Jenkins

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis mā Laura Fabbri, Samuel Moss, Fasihul Khan, Wenjie Chi, Jun Xia, Karen A. Robinson, Alan R Smyth, Gisli Jenkins, Iain Stewart

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Genetic overlap between idiopathic pulmonary fibrosis and COVID-19 mā Richard J. Allen, Beatriz Guillén‐Guío, Emma Croot, Luke M. Kraven, Samuel Moss, Iain Stewart, Gisli Jenkins, Louise V. Wain

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
20

Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey mā Manuela Funke-Chambour, Philipp Suter, Gisli Jenkins, Letícia Kawano-Dourado, Christopher J. Ryerson, Athol U. Wells, Michael Kreuter, Kerri A. Johannson

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Gisli Jenkins

Suicide rate 22 years after parasuicide: cohort study mā Gisli Jenkins

Ligation of protease-activated receptor 1 enhances v 6 integrin-dependent TGF- activation and promotes acute lung injury mā Gisli Jenkins

The pathogenesis of idiopathic pulmonary fibrosis mā William R. Coward, Gauri Saini, Gisli Jenkins

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy mā Peter M. George, Athol U. Wells, Gisli Jenkins

Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis mā James M. May, Jane A. Mitchell, Gisli Jenkins

COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts mā Alison E. John, Chitra Joseph, Gisli Jenkins, Amanda L. Tatler

Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis mā William R. Coward, Keira Watts, Carol Feghali‐Bostwick, Gisli Jenkins, Linhua Pang

A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase‐2 in idiopathic pulmonary fibrosis mā William R. Coward, Carol Feghali‐Bostwick, Gisli Jenkins, Alan J. Knox, Linhua Pang

Interplay between EZH2 and G9a Regulates<i>CXCL10</i>Gene Repression in Idiopathic Pulmonary Fibrosis mā William R. Coward, Stephan Brand, Alice Pasini, Gisli Jenkins, Alan J. Knox, Linhua Pang

Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in<i>ex vivo</i>precision-cut lung slices mā Amanda L. Tatler, Josephine L. Barnes, Anthony Habgood, Amanda Goodwin, Robin J. McAnulty, Gisli Jenkins

British Thoracic Society survey of rehabilitation to support recovery of the post-COVID-19 population mā Sally Singh, Amy Barradell, Neil Greening, Charlotte E. Bolton, Gisli Jenkins, Louise Preston, John R. Hurst

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19 mā Fasihul Khan, Iain Stewart, Laura Fabbri, Samuel Moss, Karen A. Robinson, Alan R Smyth, Gisli Jenkins

Emerging therapeutic opportunities for integrin inhibitors mā Robert J. Slack, Simon J. F. Macdonald, James A. Roper, Gisli Jenkins, Richard J. D. Hatley

Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis mā Francesco Lombardi, Iain Stewart, Laura Fabbri, Wendy Adams, Letícia Kawano-Dourado, Christopher J. Ryerson, Gisli Jenkins

The rising incidence of idiopathic pulmonary fibrosis in the UK mā Vidya Navaratnam, Kate M. Fleming, Joe West, C. J. P. Smith, Gisli Jenkins, A. Fogarty, Richard Hubbard

Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia mā Rebecca J Calthorpe, Caroline Poulter, Alan R Smyth, Don Sharkey, Jayesh Bhatt, Gisli Jenkins, Amanda L. Tatler

αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease mā Gauri Saini, Joanne Porte, Paul H. Weinreb, Shelia M. Violette, William Wallace, Tricia M. McKeever, Gisli Jenkins

Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis mā Laura Fabbri, Samuel Moss, Fasihul Khan, Wenjie Chi, Jun Xia, Karen A. Robinson, Alan R Smyth, Gisli Jenkins, Iain Stewart

Genetic overlap between idiopathic pulmonary fibrosis and COVID-19 mā Richard J. Allen, Beatriz Guillén‐Guío, Emma Croot, Luke M. Kraven, Samuel Moss, Iain Stewart, Gisli Jenkins, Louise V. Wain

Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey mā Manuela Funke-Chambour, Philipp Suter, Gisli Jenkins, Letícia Kawano-Dourado, Christopher J. Ryerson, Athol U. Wells, Michael Kreuter, Kerri A. Johannson

Ngā utauta rapu:

Ngā marau whai pānga